Skip to main content
Clinical Trials/NCT04144439
NCT04144439RecruitingPhase 4

Effect of Gamma Aminobutyric Acid on ADHD and Seizures in Children With Epilepsy.

Sherief Abd-Elsalam1 site in 1 country30 target enrollmentStarted: July 1, 2018Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Phase 4
Status
Recruiting
Sponsor
Enrollment
30
Locations
1
Primary Endpoint
Number of seizures

Study Overview

Brief Summary

Effect of GABA on ADHD and seizures in Children with epilepsy.

Detailed Description

Effect of Gamma aminobutyric acid on ADHD and seizures in Children with epilepsy.

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
4 Years to 18 Years (Child, Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Epilepsy without ADHD

Arms & Interventions

After treatment

Active Comparator

GABA

Intervention: GABA (Drug)

Outcomes

Primary Outcomes

Number of seizures

Time Frame: 6 months

Number of seizures

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Sherief Abd-Elsalam
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Sherief Abd-Elsalam

Ass. Prof. Tropical Medicine

Tanta University

Study Sites (1)

Loading locations...

Similar Trials